What is Global Corticosteroid Injections for Joint Pain Market?
The Global Corticosteroid Injections for Joint Pain Market is a specialized sector within the healthcare industry that focuses on the production and distribution of corticosteroid injections, which are used to alleviate joint pain. These injections are a common treatment for conditions such as arthritis, bursitis, and other forms of joint inflammation. The market encompasses the entire process, from the manufacturing of the injections to their distribution to healthcare providers worldwide. It also includes the research and development of new and improved corticosteroid formulations. The market is driven by the increasing prevalence of joint-related conditions, the aging global population, and the ongoing advancements in medical technology. The Global Corticosteroid Injections for Joint Pain Market is a crucial component of the broader pharmaceutical industry, contributing significantly to its growth and development.
Knee & Ankle, Hip Joint, Shoulder & Elbow, Facet Joints of the Spine, Others in the Global Corticosteroid Injections for Joint Pain Market:
The Global Corticosteroid Injections for Joint Pain Market is segmented based on the specific joints that the injections are used to treat. These include the knee and ankle, hip joint, shoulder and elbow, facet joints of the spine, and others. Each of these segments has its unique market dynamics, influenced by factors such as the prevalence of joint conditions affecting the specific joint, the effectiveness of corticosteroid injections in treating these conditions, and the availability of alternative treatments. For instance, the knee and ankle segment is likely to witness significant growth due to the high incidence of sports injuries and age-related wear and tear affecting these joints. On the other hand, the market for corticosteroid injections for the facet joints of the spine may be limited by the availability of non-invasive treatments such as physiotherapy and pain management drugs.
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies in the Global Corticosteroid Injections for Joint Pain Market:
Corticosteroid injections for joint pain are primarily used in healthcare settings such as hospital pharmacies, retail pharmacies, and online pharmacies. Hospital pharmacies are a major end-user of these injections, as they are often administered to patients as part of their treatment plan in the hospital. Retail pharmacies also stock these injections for patients who have been prescribed them for home use. The rise of online pharmacies has also contributed to the market's growth, as they offer a convenient platform for patients to purchase their medications without leaving their homes. Each of these end-user segments plays a crucial role in the overall market, influencing its growth and development in different ways.
Global Corticosteroid Injections for Joint Pain Market Outlook:
The Global Corticosteroid Injections for Joint Pain Market has shown promising growth in recent years. In 2023, the market was valued at US$ 2145 million and is projected to reach US$ 3244 million by 2030, growing at a compound annual growth rate (CAGR) of 6.1% during the forecast period from 2024 to 2030. This growth is in line with the broader pharmaceutical market, which is valued at 1475 billion USD in 2022 and is expected to grow at a CAGR of 5% over the next six years. The chemical drug market, a subset of the pharmaceutical market, is also expected to see growth, increasing from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. These trends indicate a positive outlook for the Global Corticosteroid Injections for Joint Pain Market, suggesting that it will continue to grow and develop in the coming years.
| Report Metric | Details |
| Report Name | Corticosteroid Injections for Joint Pain Market |
| Accounted market size in 2023 | US$ 2145 million |
| Forecasted market size in 2030 | US$ 3244 million |
| CAGR | 6.1% |
| Base Year | 2023 |
| Forecasted years | 2024 - 2030 |
| Segment by Type |
|
| Segment by Application |
|
| Consumption by Region |
|
| By Company | Allergan, Pfizer, Sanofi, Anika Therapeutics, Ferring, Bioventus, Flexion Therapeutics, Zimmer Biomet, SEIKAGAKU, Chugai Pharma |
| Forecast units | USD million in value |
| Report coverage | Revenue and volume forecast, company share, competitive landscape, growth factors and trends |
